Cannabis conference promises to be largest of its kind in Canada

For those interested in entering the emerging legal Canadian medical marijuana market, the International Pharmaceutical Academy is hosting a Marihuana for Medical Purposes conference in Toronto Sept 16 and 17th. Geared towards growers, producers, and researches the 2 day conference promises to be an opportunity...

For those interested in entering the emerging legal Canadian medical marijuana market, the International Pharmaceutical Academy is hosting a Marihuana for Medical Purposes conference in Toronto Sept 16 and 17th. Geared towards growers, producers, and researches the 2 day conference promises to be an opportunity to learn from industry experts, encourage research and raise awareness of the benefits of medicinal cannabis use. Held at the International Plaza Hotel, the conference will feature some 20 speakers covering the new constantly-expanding medical marijuana market from numerous angles, like regulatory requirements, licensing, legal and quality assurance concerns,  laboratory/analytical testing, facility design, cultivation and much more.

Included amongst the 20 different guest speakers will be Dr. Mark Ware, McGill university , Dr. Linda Parker, University of Guelph, Prof. Donald P. Land, Ph.D. of Steep Hill Halent Laboratories, and Joshua Wurzer, Co-founder and Director of Laboratory Operations, SC Laboratories. The conference promises to be the largest of it's kind in Canada.

Dr. Ware, Executive Director, Canadian Consortium for the Investigation of Cannabinoids (CCIC), Director of Clinical Research, Pain Clinic - McGill University Health Centre (MUHC), and Assistant Professor, Departments of Family Medicine and Anesthesia, McGill University, Montreal QC is known for being an outspoken proponent of the possibilities offered by cannabis research. His presentation will present the scientific rational for the use of cannabinoids in pain management, from preclinical to clinical research perspective, highlighting the complexities involved in considering cannabis and cannabinoids as a therapy for pain, including balancing risk and benefit, setting goals for treatment and adequate screening and follow-up. For those interested in the complexities of prescribing medical marijuana under Canada's new MMPR system, and the controversy surrounding it, this will likely prove to be a very useful presentation.

Dr. Linda Parker is a behavioral neuroscientist currently investigating chemicals found naturally in the human body that mimic those in marijuana. Her research has shown how the endocannabinoid system is related to the regulation of nausea. Professor Land, from Steep Hill in California, the company who developed the first microbiological method for determining mold and bacteria levels on cannabis, will be discussing Cannabinoid and terpene screenings and Analytical Testing Specification. Understanding cannabinoid and terpene profiles help the medical community better understand the benefits offered by specific strains and even batches of cannabis.

The conference will not only cover medical issues. One emerging aspect of the new MMPR is the need for qualified Quality Assurance Practice agents to assist Licensed Producers in properly insuring processes and testing methodologies required by Health Canad are being followed. Recent recalls highlight the need for good QAP. Announcements from Health Canada in the past stating a need for full time Quality Assurance reps and that smaller LP's can't 'share' QA representatives has created a new rush to fill demand for qualified QA reps within the Industry.

Several legal experts will also be presenting, including an analysis of the fundamental differences between Canadian and U.S. Regulatory Approaches to Medical Cannabis Cultivation and Distribution. For those interested in Quality Assurance, cultivation, production, or simply are interested in learning more about the research going on in the world of medical cannabis and the emerging industry surrounding it, this conference could prove to be a useful networking and educational experience.

Early registration for the conference goes until August 15, 2014 for a cost of $675 +HST. After August 16th, the cost increases to $875. Students, government agencies and NGOs will pay $400, plus HST. Please see their website for more information. IPA is an affiliate of the Canadian Academy of Applied Pharmaceutical Sciences based in Toronto, and the company been hosting conferences and seminars and online training in the pharmaceutical industry since 2005. Lift is proud to be a media sponsor of this event.

www.ipacanada.com/Marihuana_Medical_Purposes_2014/mmp_to_agenda.php

In this article

Join the Conversation

2 comments

  1. Chris Enns Reply

    The R v. Smith BCCA decision just repealed cannabis prohibition by reminding us that when there is no constitutionally sound exemption scheme, there is no active marijuana prohibition.

  2. Anthony SaugaStonerSociety Reply

    oh I'll be there.... not inside - but out. I've got a message that needs to get across in regards to the MMPR and no it's not the usual protests you hear.

    This is a protest from a patient of the MMPR who has been wrongfully charged with possession of cannabis and this is due to the incompetence of the Ministry of Justice not sending out a file to police departments updating them on these regulations.
    Toronto Police informed me that the MMPR doesn't exist and I must be the only person on said program.
    I urge all of you to write letters to your MPs and to the Ministry of Justice demanding something be done about this problem. if it happened to me it can (and probably has) happened to others, or even you!